ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Medicare Program: HCFA Expands Coverage Of Cancer Screening Methods

January 9, 1998

NCI Beings Accelerated Review Of R01s That just Miss Payline

March 29, 1996

NCCS Networker Volume 8 Issue 4, Winter 1994

January 13, 1994

Gates, Bloomberg Fund Project To Reduce Tobacco Use.

July 25, 2008

Xgeva Significantly Increases Bone Metastasis-Free Survival

May 27, 2011

Study: Routine CT Not Needed In Detecting DLBCL Remissions

May 31, 2013